These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 31034953)
1. Anti-inflammatory and antioxidative effects of Dan-Lou tablets in the treatment of coronary heart disease revealed by metabolomics integrated with molecular mechanism studies. Li Z; Yang L; Liu Y; Xu H; Wang S; Liu Y; Zhao H; Xie J; Gao S; Gao S; Xu Y; Li L; Li Y; Yu C J Ethnopharmacol; 2019 Aug; 240():111911. PubMed ID: 31034953 [TBL] [Abstract][Full Text] [Related]
2. Dan-Lou tablets reduce inflammatory response by inhibiting the activation of NLRP3 inflammasome for coronary heart disease. Gao S; He Y; Liu Y; Yu L; Cheng Q; Wang S; Li L; Cui Y; Yu C; Li Z Phytomedicine; 2024 Aug; 131():155773. PubMed ID: 38833946 [TBL] [Abstract][Full Text] [Related]
3. Dan-Lou tablets reduces inflammatory response via suppression of the MyD88/p38 MAPK/NF-κB signaling pathway in RAW 264.7 macrophages induced by ox-LDL. Li Z; Cheng Q; Yu L; He YY; Gao LN; Wang Y; Li L; Cui YL; Gao S; Yu CQ J Ethnopharmacol; 2022 Nov; 298():115600. PubMed ID: 35970313 [TBL] [Abstract][Full Text] [Related]
4. Clinical metabolomic analysis of Danlou tablets with antioxidant effects for treating stable angina pectoris. Li Y; Zhao H; Du J; Jiao Z; Shen D; Gao S; Zheng Y; Li Z; Li L; Wang Y; Yu C J Pharm Biomed Anal; 2022 Sep; 219():114922. PubMed ID: 35850016 [TBL] [Abstract][Full Text] [Related]
5. Regulation of phospholipid peroxidation signaling by a traditional Chinese medicine formula for coronary heart disease. Ma X; Wang Q; Liu C; Liu J; Luo G; He L; Yuan T; He RR; Yao Z Phytomedicine; 2023 Jun; 114():154749. PubMed ID: 36931097 [TBL] [Abstract][Full Text] [Related]
6. A network pharmacology integrated pharmacokinetics strategy for uncovering pharmacological mechanism of compounds absorbed into the blood of Dan-Lou tablet on coronary heart disease. Ding M; Ma W; Wang X; Chen S; Zou S; Wei J; Yang Y; Li J; Yang X; Wang H; Li Y; Wang Q; Mao H; Gao XM; Chang YX J Ethnopharmacol; 2019 Oct; 242():112055. PubMed ID: 31276751 [TBL] [Abstract][Full Text] [Related]
7. UPLC-QTOF/MS-based metabolomics analysis of plasma reveals an effect of Xue-Fu-Zhu-Yu capsules on blood-stasis syndrome in CHD rats. Zhao Y; Nie S; Yi M; Wu N; Wang W; Zhang Z; Yao Y; Wang D J Ethnopharmacol; 2019 Sep; 241():111908. PubMed ID: 31029757 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect and mechanism of danshensu on coronary heart disease using liquid chromatography combined with mass spectrometry metabolomics. Zhou P; An B; Zhang X; Lv J; Lin B J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Oct; 1208():123400. PubMed ID: 35917776 [TBL] [Abstract][Full Text] [Related]
9. Serum and urine metabolomics based on UPLC-Q-TOF/MS reveals the antipyretic mechanism of Reduning injection in a rat model. Gao X; Huang C; Geng T; Chen X; Wang J; Liu J; Duan K; Cao L; Wang Z; Xiao W J Ethnopharmacol; 2020 Mar; 250():112429. PubMed ID: 31812644 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Chemical Profiles, Anti-Inflammatory Activity, and UPLC-Q-TOF/MS-Based Metabolomics in Endotoxic Fever Rats between Synthetic Borneol and Natural Borneol. Zou L; Zhang Y; Li W; Zhang J; Wang D; Fu J; Wang P Molecules; 2017 Aug; 22(9):. PubMed ID: 28858264 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of Xuefu Zhuyu Decoction in the treatment of coronary heart disease based on integrated metabolomics and network pharmacology approach. Yang Y; Su C; Zhang XZ; Li J; Huang SC; Kuang HF; Zhang QY J Chromatogr B Analyt Technol Biomed Life Sci; 2023 May; 1223():123712. PubMed ID: 37060624 [TBL] [Abstract][Full Text] [Related]
12. [Metabolomics of interventional effects of Coptidis Rhizoma and its processed products on oral ulcer due to excess heat in rats]. Zhang ZK; Zheng YJ; Zhang BX; Wang YX; Zhang JY; Cao YM; Feng WS; Zheng XK; Zhou N Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):389-402. PubMed ID: 38403315 [TBL] [Abstract][Full Text] [Related]
13. Metabolic profiles revealed anti-ischemia-reperfusion injury of Yangxinshi tablet in Rats. Zhang H; Zhao Y; Xia Z; Du H; Gao Y; Xue D; Zhu Z; Chai Y J Ethnopharmacol; 2018 Mar; 214():124-133. PubMed ID: 28889959 [TBL] [Abstract][Full Text] [Related]
14. Plasma metabolomics-based reveals the treatment mechanism of ShenGui capsule for application to coronary heart disease in a rat model. Wang D; Guo J; Liu T; Zhou X; Yang Z; Shi C; Wang W; Li R; Zhang Y; Junzhang ; Yan J; Zhu X; Li Y; Gong M; Cui Y; Wu X Anal Biochem; 2022 Apr; 642():114480. PubMed ID: 34813769 [TBL] [Abstract][Full Text] [Related]
15. The Therapeutic Role of Slit2 in Anti-fibrosis, Anti-inflammation and Anti-oxidative Stress in Rats with Coronary Heart Disease. Liu JW; Liu HT; Chen L Cardiovasc Toxicol; 2021 Dec; 21(12):973-983. PubMed ID: 34410632 [TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory activity of the Tongmai Yangxin pill in the treatment of coronary heart disease is associated with estrogen receptor and NF-κB signaling pathway. Fan Y; Liu J; Miao J; Zhang X; Yan Y; Bai L; Chang J; Wang Y; Wang L; Bian Y; Zhou H J Ethnopharmacol; 2021 Aug; 276():114106. PubMed ID: 33838287 [TBL] [Abstract][Full Text] [Related]
17. Unraveling the pharmacodynamic substances and possible mechanism of Trichosanthis Pericarpium in the treatment of coronary heart disease based on plasma pharmacochemistry, network pharmacology and experimental validation. Zhang XY; Xia KR; Wang YN; Liu P; Shang EX; Liu CY; Liu YP; Qu D; Li WW; Duan JA; Chen Y; Zhang HQ J Ethnopharmacol; 2024 May; 325():117869. PubMed ID: 38342153 [TBL] [Abstract][Full Text] [Related]
18. Metabolomic analysis of biochemical changes in the plasma and urine of collagen-induced arthritis in rats after treatment with Huang-Lian-Jie-Du-Tang. Zhang H; Fu P; Ke B; Wang S; Li M; Han L; Peng C; Zhang W; Liu R J Ethnopharmacol; 2014 May; 154(1):55-64. PubMed ID: 24709313 [TBL] [Abstract][Full Text] [Related]
19. Metabolic profiling of copper-laden hepatolenticular degeneration model rats and the interventional effects of Gandou decoction using UPLC-Q-TOF/MS. Cheng M; Wu H; Wu H; Liu X; Zhou A J Pharm Biomed Anal; 2019 Feb; 164():187-195. PubMed ID: 30390561 [TBL] [Abstract][Full Text] [Related]
20. Urinary metabonomic study of Panax ginseng in deficiency of vital energy rat using ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Lin H; Pi Z; Men L; Chen W; Liu Z; Liu Z J Ethnopharmacol; 2016 May; 184():10-7. PubMed ID: 26921673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]